about
Treatment of cytokine-induced depression.Infection, treatment and immune response in patients with bipolar disorder versus patients with major depression, schizophrenia or healthy controls.A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalenceOlanzapine and clozapine differently affect sleep in patients with schizophrenia: results from a double-blind, polysomnographic study and review of the literature.Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression.Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.[Experimental studies on the interaction between sleep and the immune system in humans].Perinatal MK-801 treatment affects age-related changes in locomotor activity from childhood to later adulthood in rats.Impairment of visuospatial memory is associated with decreased slow wave sleep in schizophrenia.Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).A flow-cytometric method to investigate glutamate-receptor-sensitivity in whole blood platelets - results from healthy controls and patients with schizophrenia.Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.Delay of gratification and executive performance in individuals with schizophrenia: putative role for eating behavior and body weight regulation.Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine.Sleep in major depression: relation to memory performance and outcome after interpersonal psychotherapy.Effects of short- and long-term pulsed radiofrequency electromagnetic fields on night sleep and cognitive functions in healthy subjects.Morning headaches in patients with sleep disorders: a systematic polysomnographic study.The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients.[Signals for the initiation of structured diagnostic procedures for depression in primary health care. A practice-relevant evaluation of international guidelines].
P50
Q34980861-CC1F39A0-1160-45BB-8D14-047B8FB18774Q35024545-82CE5389-ECBA-4355-90D1-8D0E8A5F1F83Q36853287-D73FD3F6-CD26-462B-A7A1-75E4EEB443FBQ38169369-0B2D11E9-8479-417D-9F97-9CB722AF0320Q39278195-342E19DA-9497-4ED6-930E-91E1087E430EQ40407932-76B7FA90-08A8-49DA-BA41-A0A98DE47F14Q40517236-C97F59E1-239C-4C47-9341-A37B9996596DQ44843060-E645E6C9-50E3-479C-BE3E-41A482A95CCFQ45086275-30D0C98B-84C1-4CA7-8073-826797124745Q46417496-7F7D58A7-D6EB-4C14-ADA0-FFBC9A453241Q46417860-1B4F06C5-A9D9-413A-A36B-028FF74117C8Q46899624-D9E79C85-BB4B-4859-9F87-483D229189B0Q47312878-6E4517D0-F750-4C35-9557-0AB045CD2238Q48263039-F0B05852-EF65-4CB2-A860-612E91B6D675Q48466420-91072EB6-7C4D-46EF-B8E8-F59389162785Q48480632-1B19B62F-3927-495E-951B-3CBE72056029Q48613423-8DBA53DF-686C-4895-B10A-EABE922E9AE2Q49138931-51CB0365-10D4-4270-A0EF-6FDE007DD130Q50770325-A16D3915-1B9D-4D7B-89E4-975F18667141
P50
name
Dunja Hinze-Selch
@ast
Dunja Hinze-Selch
@de
Dunja Hinze-Selch
@en
Dunja Hinze-Selch
@es
Dunja Hinze-Selch
@nl
type
label
Dunja Hinze-Selch
@ast
Dunja Hinze-Selch
@de
Dunja Hinze-Selch
@en
Dunja Hinze-Selch
@es
Dunja Hinze-Selch
@nl
prefLabel
Dunja Hinze-Selch
@ast
Dunja Hinze-Selch
@de
Dunja Hinze-Selch
@en
Dunja Hinze-Selch
@es
Dunja Hinze-Selch
@nl